Jubilant Pharmova Limited has informed the Exchange about General Updates - Receipt of rectification order from the Income tax department
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts less than Nifty Smallcap 250 and 0.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jubilant Pharmova has received a rectification order from the Income Tax department dated May 8, 2025, fully deleting a prior tax demand of Rs. 35.90 crores for Assessment Year 2018-19. The company had filed a rectification application against the demand, and the order received on June 10, 2025, cancels the demand entirely. The company has clarified that a separate appeal on merit grounds is still being pursued before CIT(A), so other tax matters remain under review. No penalty, settlement, or financial impact details have been disclosed in this update.
Positive for shareholders as the full deletion of the Rs. 35.90 crore tax demand removes a potential liability; however, the ongoing merit-based appeal means tax-related uncertainty has not been fully resolved.